Geode Capital Management, LLC Bio Techne Corp Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,838,210 shares of TECH stock, worth $296 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,838,210

Previous 3,721,727 3.13%

Holding current value

$296 Million

Previous $287 Million 5.92%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$65.98 - $77.09 $7.69 Million - $8.98 Million	116,483 Added 3.13%	3,838,210 $270 Million
Q4 2023 Feb 13, 2024	BUY	$52.83 - $78.22 $5.45 Million - $8.07 Million	103,220 Added 2.85%	3,721,727 $287 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $4.98 Million - $6.6 Million	73,776 Added 2.08%	3,618,507 $246 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $14.5 Million - $16.9 Million	-196,440 Reduced 5.25%	3,544,731 $289 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $4.69 Million - $5.67 Million	65,432 Added 1.78%	3,741,171 $278 Million

Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $225 Million - $982 Million	2,788,348 Added 314.22%	3,675,739 $304 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $28.4 Million - $39.4 Million	100,557 Added 12.78%	887,391 $252 Million
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $433,668 - $604,329	1,344 Added 0.17%	786,834 $272 Million
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $7.97 Million - $11 Million	22,537 Added 2.95%	785,490 $339 Million
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $14 Million - $16.1 Million	30,699 Added 4.19%	762,953 $394 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $76.9 Million - $93.2 Million	172,930 Added 30.92%	732,254 $354 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $9.35 Million - $10.9 Million	24,149 Added 4.51%	559,324 $252 Million
Q1 2021 May 12, 2021	SELL	$314.62 - $411.0 $8.44 Million - $11 Million	-26,819 Reduced 4.77%	535,175 $204 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $1.78 Million - $2.32 Million	7,216 Added 1.3%	561,994 $178 Million
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $5.72 Million - $6.97 Million	-24,622 Reduced 4.25%	554,778 $137 Million
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $13.6 Million - $20.5 Million	73,360 Added 14.5%	579,400 $153 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $2.41 Million - $3.32 Million	14,982 Added 3.05%	506,040 $96 Million
Q4 2019 Feb 13, 2020	BUY	$189.68 - $222.09 $7.36 Million - $8.62 Million	38,825 Added 8.59%	491,058 $108 Million
Q3 2019 Nov 12, 2019	BUY	$183.56 - $216.72 $1.78 Million - $2.1 Million	9,708 Added 2.19%	452,233 $88.5 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $3.08 Million - $3.52 Million	16,329 Added 3.83%	442,525 $92.3 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $1.32 Million - $1.94 Million	9,700 Added 2.33%	426,196 $84.6 Million
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $3.66 Million - $5.62 Million	27,587 Added 7.09%	416,496 $60.3 Million
Q3 2018 Nov 13, 2018	BUY	$147.44 - $204.11 $5.17 Million - $7.15 Million	35,033 Added 9.9%	388,909 $79.4 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $1.73 Million - $1.98 Million	11,932 Added 3.49%	353,876 $52.4 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $561,597 - $645,242	4,272 Added 1.27%	341,944 $51.6 Million
Q4 2017 Feb 13, 2018	BUY	$121.17 - $134.75 $809,536 - $900,264	6,681 Added 2.02%	337,672 $43.7 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $1.75 Million - $1.91 Million	15,407 Added 4.88%	330,991 $40 Million
Q2 2017 Aug 14, 2017	BUY	N/A	315,584	315,584 $37.1 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Bio Techne Corp Transaction History